Canaural contains fusidic acid, framycetin and nystatin for their antibacterial and antifungal effects against the most common organisms associated with otitis externa.
Fusidic acid has skin penetrating properties and is active against staphylococci and streptococci1. Framycetin is active against Gram negative species. Dechra says the combination of the two provides an enhanced antibacterial effect on the most common bacterial cause of canine otitis2.
Nystatin is active against malassezia and prednisolone helps to provide anti-inflammatory and anti-pruritic action.
Dechra Brand Manager Carol Morgan said: “The reintroduction of Canaural to the veterinary treatment market means that once again veterinarians have this reliable and effective treatment available to tackle one of the most common canine complaints.
"Canaural is a tried and tested product and a recent study showed that fusidic acid is highly efficacious against both methicillin sensitive and methicillin resistant strains of Staphylococcus pseudintermedius3. Canaural remains as relevant today as it has ever been."
Canaural comes in 15 ml and 25 ml bottle sizes and is now available in veterinary wholesalers.
References
The Oncology Working Group, winningly styled as 'WOW', says it hopes that the glossary will give owners a clearer understanding of the diagnosis and management choices they have, and help them discuss care with their veterinary surgeon from a more informed perspective.
The glossary is the first output from the WOW Group which was formed in 2021 to raise awareness of the latest thinking in cancer therapy and promote best practice globally.
The glossary is available to download free from the WSAVA website at: https://wsava.org/wp-content/uploads/2021/11/Glossary-WOW-13.11.2021.pdf
WOW Group Member Professor Nick Bacon, a RCVS-Recognized Specialist in Small Animal Surgery (Oncology) and a European Specialist in Small Animal Surgery, said: “Cancer has a language all of its own and, during our early WOW Group discussions, it became obvious that, in order to improve communication between veterinary professionals and owners, there was an urgent need for a globally accessible resource to help owners better understand cancer terminology.
“Our Oncology Glossary is the result.
"We hope it will enable owners to feel on a more equal footing when they are discussing their pet’s condition with veterinary professionals.
"We hope it will also increase the consistency and effectiveness of communication about veterinary oncology globally.”
He added: “We will update the Oncology Glossary regularly and are now working on the development of further practical and easy-to-use tools to support veterinarians working in this rapidly evolving area of veterinary medicine.
"In the meantime, more resources are available on our web page at https://wsava.org/committees/oncology-working-group/”
The company points to research which shows that half of all pets around the world are reported to be overweight1.
That, of course, places extra load on the joints.
The new diet has been formulated to help dogs lose weight whilst still getting optimal levels of nutrients.
To help with weight loss, Hill's says it has added ingredients which change overweight pets’ gene expression and activate the metabolism to burn excess body fat.
The diet also contains omega-3-rich fish oil to support joint mobility, antioxidants and vitamins to reduce inflammation and support the immune system, and glucosamine and chondroitin, the building blocks of joint cartilage.
The diet comes in four sizes, one for small and mini dogs (1.5kg), two for medium (2.5kg, 12kg), and one for large breeds (12kg).
Hillary Noyes, Hill’s Veterinary Affairs Manager, UK & Republic of Ireland, said: "Excessive weight can increase a dog’s chances of developing mobility issues which can have a hugely detrimental effect on the animal’s health and quality of life.
"Our new Science Plan Perfect Weight & Active Mobility is the perfect solution for those who want to help their best friend maintain a healthy weight and support joints at the same time. "
For more information, speak to your local Territory Manager or visit https://www.hillspet.co.uk/dog-food/sp-canine-adult-perfect-weight-and-active-mobility-medium-chicken-dry
Reference
There were two charges against Dr Mulvey. The first was that, between May and October 2018, she failed to provide the clinical history for an English Cocker Spaniel named Henry to the Tremain Veterinary Group, despite numerous requests. Also, that between August 2018 and October 2018, she failed to respond adequately or at all to Henry’s owner's requests for information, particularly his clinical records and details of insurance claims made for Henry by her practice.
The second charge was that in January/February 2019, she failed to respond to reasonable requests from the RCVS, particularly in relation to her treatment of Henry, her continuing professional development (CPD) and the status of her Professional Indemnity Insurance.
At the beginning of the hearing, Dr Mulvey admitted the facts and conduct alleged in the charges and also admitted that when her conduct was considered cumulatively, she was guilty of disgraceful conduct in a professional respect.
The Committee, having considered the evidence provided by the College and Dr Mulvey’s admissions found all the facts and conduct to be proved.
The Committee also concluded that Dr Mulvey's failure to respond to Henry's owners and to the College amounted to disgraceful conduct both when considered individually and cumulatively.
In respect of the first charge, the Committee decided that Dr Mulvey had breached the Code of Professional Conduct for Veterinary Surgeons by failing to provide clinical records or details of insurance claims.
This was an administrative part of the function of a veterinary surgeon’s role and that failure to provide clients with such information was unacceptable and fell far short of acceptable professional standards. The Committee noted that Dr Mulvey’s failure to provide details of insurance claims had occurred because she had not made those claims, despite offering to do so.
With regard to the second charge, the Committee concluded that Dr Mulvey’s failure to respond to five requests from the College for information about Henry was unacceptable.
The Committee also considered that the omissions took place in the context of Dr Mulvey’s previous Disciplinary Committee hearing in April 2018 during which she agreed to a number of undertakings including supervision on her professional practice by an appointed supervisor. It therefore decided that her failure to provide evidence of her CPD and Professional Indemnity Insurance to the College each individually amounted disgraceful conduct in a professional respect.
The Committee then went on to consider the sanction for Dr Mulvey in relation to the both charges that it had found proved and also in respect of the charges it had found proved at its earlier hearing on 26 April 2018 for which sanction had been postponed for a period of 1 year to enable Dr Mulvey to comply with undertakings she gave to the Committee to ensure that her practice met RCVS Core Standards by May 2019.
The Committee heard from Mr Stuart King MRCVS who had been appointed to act as a Workplace Supervisor for Dr Mulvey during the period of her Undertakings. Mr King provided the Committee with a report upon the extent to which Dr Mulvey had complied with the terms of her undertakings including the extent which she had implemented Dr King’s numerous recommendations.
The Committee also heard from Dr Byrne MRCVS an inspector for the RCVS’s voluntary Practice Standards Scheme that Dr Mulvey’s practice, when inspected by him in early April 2019, had not met RCVS PSS Core standards in a number of areas.
The Committee heard from Dr Mulvey and her Counsel that she accepted that she had not met RCVS Core standards as she had undertaken to do.
In reaching its decision as to sanction for all the matters, the Committee took into account that Dr Mulvey’s misconduct overall was serious because it was repeated.
The Committee also considered aggravating and mitigating factors.
Aggravating factors included the fact that the misconduct was sustained or repeated over a period of time (in relation to charge 1 for a period of approximately 4 months and in relation to charge 2 for approximately 6 weeks).
Other aggravating factors include the fact that Dr Mulvey’s conduct contravened advice issued by the Professional Conduct Department in letters sent to her, and that she had wilfully disregarded the role of the RCVS and the systems that regulate the veterinary profession.
Mitigating factors included that: there was no harm to any animal; there was no financial gain for Dr Mulvey or any other party; there was no ulterior motive behind Dr Mulvey’s conduct; and that Dr Mulvey had in fact both completed her minimum CPD requirement and secured Professional Indemnity Insurance, demonstrating that she had not attempted to hide such information from the College.
It also took into account that Dr Mulvey, prior to the first Disciplinary Committee’s hearing in 2018, worked without any previous disciplinary findings against her from 1976 to 2018. The Committee also noted that she had made efforts to comply with some of the undertakings.
Mr Ian Green, Chair of the DC and speaking on behalf of the Disciplinary Committee, said: "The Committee considered that a warning or reprimand was not an appropriate sanction that would meet the public interest. Instead, the Committee decided that a suspension order for a period of six months would allow Dr Mulvey sufficient time to focus on ensuring her practice met the Core Standards set out in the Practice Standards Scheme, without the daily demands of practising as a veterinary surgeon, and was a proportionate and sufficient sanction to meet the public interest.
"The Committee was satisfied that a period of six months met the public interest as it was sanctioning Dr Mulvey for two sets of similar misconduct which we had determined overall as serious. The Committee also believed that during these six months Dr Mulvey could reflect and reorganise her practice, and there would be little risk to animals and the public in her returning to practice."
Dr Mulvey has 28 days from being informed of the Committee’s decision to lodge an appeal with the Privy Council.
The AHT has published the first research paper of its kind which looks at idiopathic epilepsy (IE) in the Italian Spinoni, a breed where the prevalence of IE has been found to be 5.3%, compared to 0.6% estimated to be seen in dogs generally in UK first opinion practice.
Dr Luisa De Risio, Head of Neurology at the AHT and lead researcher on the paper, said: "Idiopathic epilepsy is the most common chronic neurologic disorder in dogs but it can be more common in some breeds than others, for example Irish Wolfhounds, Border Collies and Italian Spinoni. Sadly, we see a lot epileptic dogs in our clinic, including these breeds as well as Golden Retrievers and Labrador Retrievers, so research being undertaken at the AHT, and around the world, is very important in helping owners of dogs with epilepsy to be able to control the effects of the disease.
"The Italian Spinone is a wonderful breed but is highly affected by idiopathic epilepsy. To our knowledge, no one has conducted such a large-scale research study in this breed to be able to gain a better understanding of how the epilepsy manifests, how prevalent it really is and, importantly, which factors may contribute to survival in these dogs.
"With the backing of the Italian Spinone Club of Great Britain, the AHT was able to design a questionnaire for the research study and work with the Kennel Club to invite over 3,000 Kennel Club registered Italian Spinone owners to aid our research by completing the questionnaire.
"1,192 owners participated in the research and of this sample, 63 Italian Spinoni had IE. Owners of affected dogs were then invited to complete a further questionnaire and asked to make the dog's medical records available. This gave us a very large amount of data to analyse from which we were able to glean a lot of very useful information about the clinical characteristics of idiopathic epilepsy in Italian Spinoni."
The research also looked at survival times of those dogs in the study with IE. Survival was significantly longer in Italian Spinone with no cluster seizures and in Italian Spinone in which antiepileptic medication was initiated after the second seizure rather than after more than three seizures.
Luisa continued: "From this sample we were able to conclude that idiopathic epilepsy in this breed often has a severe presentation but starting treatment with antiepileptic medication after the second seizure, and aggressive treatment of cluster seizures, may improve the survival of these dogs.
"The input in treatment design and modulation by a specialist veterinary neurologist with expertise in canine epilepsy can help to optimise treatment success and the dog's quality of life.
"We hope these findings will help to increase veterinary knowledge and understanding of this horrible disease and give Italian Spinoni, and other affected breeds, the best chance of fighting IE.
"Epilepsy is one of the most complex and difficult diseases to treat, with several variables in any case, but it is important for owners not to give up hope and to seek a consultation with a veterinary neurologist who specialises in epilepsy, if possible."
The next phase of the AHT's research in the Italian Spinone is to identify the genetic basis of this condition, with the aim of identifying the genetic mutations responsible so that a genetic test could be created. This research is currently on-going in Italian Spinoni and Border Collies and requires more DNA samples from affected and unaffected dogs.
Luisa said: "A genetic test is the only way to successfully help breeders identify carriers and select matings which are most likely to produce unaffected dogs. However, the genetics, like the condition itself, are very complex so the development of such a test is still likely to be many years away. The most we can do for these lovely dogs now is to share these findings across the veterinary profession and to do our best to treat each dog as well as we can."
The full paper is titled 'Idiopathic Epilepsy in the Italian Spinone in the United Kingdom: Prevalence, Clinical Characteristics, and Predictors of Survival and Seizure Remission' and is published in the Journal of Veterinary Internal Medicine on an open-access basis.
Photo: © Caroline Granycome
MMI seeks to address mental health and wellbeing issues within the veterinary profession, while the Doctors’ Support Network provides peer support for doctors and medical students with mental health concerns.
&me was launched this time last year at the Palace of Westminster at an event sponsored by Kevan Jones MP (Labour, North Durham,) who has spoken about his own experiences with depression.
Overall eleven &me ambassadors have volunteered their own stories with mental ill-health:
A number of &me ambassadors will be taking part in an ‘&me live’ session at BSAVA Congress, from 5-8 April 2018 in Birmingham, providing a short overview of their story before taking questions from the audience. The session will take place from 8.30 to 10.10am on Saturday 7 April and will be open to all those attending Congress.
Lizzie Lockett, RCVS CEO and Mind Matters Director, said: "The feedback our &me ambassadors have received is truly heartening.
"Steve Carter, for example, had both an ex-student and colleague comment on his story thanking him for all he’s done, while a Facebook post about Rob Pettitt reached nearly 25,000 people.
"The campaign highlights how it is possible to recover from mental ill-health and flourish in your career, with the aim of encouraging those at the start of their mental ill-health experience to seek appropriate help, whether that is something profession-specific, such as Vetlife or DSN, or their GP."
Louise Freeman, Co-Chair of the DSN, added: "Many healthcare professionals face similar pressures that can lead to mental ill-health, including long hours, intense pressure, and the nature of the job which requires practitioners to constantly provide care for others, without necessarily recognising the need for self-care at the same time.
"A recurring theme that we’ve seen from these ambassadors’ stories has been that they drew on support from friends and family, and we really hope that this campaign encourages other professionals to seek help if they feel they are struggling."
The campaign is interested in hearing from not only doctors and veterinary surgeons but also nurses, veterinary nurses, dentists, pharmacists and other healthcare professionals who want to open up about their experiences of mental ill-health.
To participate in the campaign, email Dr Louise Freeman on vicechair@dsn.org.uk.
Further information about the ‘&me’ campaign can be found at www.vetmindmatters.org/&me, and a blog by Louise, 'Me and #AndMe', can be found at www.vetmindmatters.org/me-and-andme/.
The responsible use of antibiotics termed critically important is an important strand in the UK policy to fight antibiotic resistance development.
However, NOAH says there is much confusion about which antibiotics should be considered within this group, with different organisations referring to different classes.
Donal Murphy, Head of Technical and Regulatory Affairs at NOAH said: "NOAH believes the classification and use of antibiotics in veterinary medicine should be driven and guided by the regulators, who are independent and make science based decisions and recommendations.
"Of course, all classes of antibiotics, whether critically important or not, should be used responsibly and guided by the principle outlined by the Responsible Use of Medicines in Agriculture Alliance (RUMA) who state they should be used 'as little as possible but as much as necessary'. The use of these important products in this manner can ensure that the availability and efficacy of antibiotics can be maintained to ensure animal health and welfare in the future."
You can download the briefing document here.
This is the first confirmed finding of the virus in the UK this winter and tests have shown it is closely related to the H5N6 strain that has been circulating in wild birds across Europe in recent months. This is different to the strains which affected people in China last year and Public Health England have advised the risk to public health is very low. The Food Standards Agency have said that bird flu does not pose a food safety risk for UK consumers.
UK Chief Veterinary Officer, Nigel Gibbens, said: "This is the first time avian flu has been identified in the UK this winter and while the disease does not represent a threat to the public, it is highly infectious and deadly to birds.
"As the virus has been circulating across Europe, this finding has not come as a surprise. But it is vital that anyone who keeps birds - whether a few in a back garden or thousands on a farm - is vigilant for any signs of disease, reports suspect disease to APHA and maintains good biosecurity to reduce the risk of their birds becoming infected."
Local measures will be put in place to manage the potential threat. These include a local Avian Influenza Prevention Zone (AIPZ) in Dorset as a precautionary measure to prevent disease spread to other birds. This means all captive bird keepers in the area will have to implement enhanced biosecurity measures such as feeding and watering birds undercover so that wild birds do not co-mingle with kept birds; minimising movement in and out of bird enclosures; cleaning and disinfecting footwear; and keeping areas where birds live clean and tidy.
There are no plans for culling or movement restrictions.
BVA President John Fishwick said: "I’d encourage vets to reassure their clients that this strain of Avian Influenza poses a very low risk to public health and the food chain. Defra have acted swiftly to try and contain further spread of the disease, which has likely come from migratory birds, yet vets and poultry owners should remain vigilant for signs of the disease."
British Veterinary Poultry Association (BVPA) President Phil Hammond added: "It’s really important that all bird keepers heed biosecurity advice issued by Defra, and maintain the highest biosecurity standards. Any suspicion of Avian Influenza should be reported to the APHA as soon as possible."
Up-to-date advice and guidance on Avian Influenza is available on the Gov.UK website, including how to spot it, what to do if you suspect it, and measures to prevent it: https://www.gov.uk/guidance/avian-influenza-bird-flu#about-avian-influenza
For further advice on Avian Influenza contact the Defra Helpline on 03459 33 55 77.
Trade should not be affected following the findings in wild birds, according to the rules of the World Animal Health Organisation (OIE).
Photo: Wild Birds, Shutterstock / aDam Wildlife
The RCVS Disciplinary Committee has directed that a veterinary surgeon from Berkshire be removed from the Register, following his administration of a prohibited substance to a racehorse and his subsequent attempts to conceal his actions.
At a six-day hearing that concluded yesterday, James Main, a partner in the O'Gorman, Slater, Main & Partners veterinary practice in Newbury, and former lead veterinary surgeon to racehorse trainer Nicky Henderson, faced four charges of serious professional misconduct concerning his treatment of Moonlit Path, a six-year-old mare owned by The Queen.
Three of the charges related to Mr Main breaching British Horseracing Authority (BHA) rules by injecting Moonlit Path with tranexamic acid (TA) on the day she was due to race; the fourth charge related to his dishonest concealment of this treatment in his practice clinical records. Nicky Henderson had himself faced a BHA Inquiry into this case in 2009 and subsequently been sanctioned.
The Committee heard that on 18 February 2009, Mr Henderson's yard requested a veterinary surgeon attend Moonlit Path to administer an injection of Dycenene the following morning. The injection was requested as the mare was prone to exercise-induced pulmonary haemorrhage. Mr Main attended on the morning of 19 February and injected the horse with intravenous tranexamic acid. Moonlit Path raced at Huntingdon later that day, along with the eventual winner, and favourite, Ravello Bay - another horse trained by Mr Henderson. Moonlit Path finished sixth and a urine sample taken from her after the race tested positive for TA.
Of the four charges, Mr Main admitted injecting Moonlit Path with TA on the day she was due to race when he knew this breached the BHA's rule prohibiting any substance other than the horse's usual feed and water being given on race day. However, Mr Main denied knowing that, if tested, a horse would test positive for TA (thereby imposing a strict liability on the trainer); he denied administering a prohibited substance to a horse with the intention to affect that horse's racing performance; and, he denied dishonestly concealing the TA injection by omitting it from his clinical records and referring to it as a 'pre-race check'.
The Committee heard and carefully considered evidence from Mr Henderson and his employees, from BHA investigating officers and its Director of Equine Science and Welfare, from an expert equine physiologist and from Mr Main himself. In its findings, the Committee stated it was "unimpressed by Mr Henderson's evidence and surprised by his apparent lack of knowledge of the rules of racing".
Whilst the Committee accepted Mr Main believed at the time that Moonlit Path would not test positive for TA, it considered he failed to fully inform himself of the medicinal product he was using; especially so as TA does not possess a Marketing Authorisation as a veterinary medicinal product. In so doing, he did not meet his professional obligation to provide Mr Henderson with the information and advice he needed.
The Committee concluded that TA was a prohibited substance and, whilst accepting that Mr Main's concern had solely been for Moonlit Path's welfare, he had actually breached BHA rules by affecting her performance through administering such a substance.
Finally, the Committee found that Mr Main had deliberately concealed the TA injection to Moonlit Path by describing it in his notes as a 'pre-race check' - a protocol developed over several years between the practice and Mr Henderson. Such inaccurate clinical records were in breach of the RCVS Guide to Professional Conduct and led the Committee to conclude he had acted dishonestly. The Committee also found Mr Main "did not act with candour" by claiming to have administered the TA injection the day before the race. On questioning by the Legal Assessor, however, he admitted that he had known that Moonlit Path was racing the same day that he administered the injection.
Professor Sheila Crispin, chairing the Committee, said: "[We] regard it as wholly unacceptable practice that a veterinary surgeon should be party to serious breaches of rules of another regulatory body in the field of animal welfare ... and which go to the very integrity of racing.
"Whilst the findings relate to a single incident, [we] are satisfied that Mr Main's actions amounted to pre-meditated misconduct ... It is highly relevant that Mr Main held positions of responsibility within the racing industry where he was required to uphold the rules and standards of the profession," she added.
Noting Mr Main's "long and hitherto unblemished career as a highly respected equine veterinary surgeon", the Committee accepted Mr Main's evidence that the reason for the administration of tranexamic acid was solely his concern about the welfare of the horse. Nevertheless, it found his evidence was "evasive, lacking in candour and on some aspects of the case his evidence was untrue".
Professor Crispin concluded: "...proven dishonesty has been held to come at the top end of the spectrum of gravity of disgraceful conduct in a professional respect ... Having considered carefully all the mitigation put forward on Mr Main's behalf, [we] have concluded that Mr Main's behaviour was wholly unacceptable and so serious that removal of his name from the Register is required."
MSD Animal Health has obtained regulatory approval in 21 European countries, including the UK, for Cobactan LA 7.5% (cefquinome) - a new-generation, injectable antimicrobial for the treatment of swine respiratory disease (SRD).
Raul Berro DVM, global marketing director swine at MSD Animal Health said: "Cobactan LA 7.5% is a long-acting version of our highly effective Cobactan 2.5%. Its longer duration of action means greater compliance for swine producers with fewer injections and less stress to the animals, without sacrificing performance."
According to the company, the long-acting antibiotic formulation is effective against three major SRD pathogens in growing and finishing pigs - Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida. Considered the most important threat to the swine industry worldwide, SRD causes increased mortality, decreased weight gain and increased feed consumption.
Cobactan LA 7.5% requires two intramuscular injections 48 hours apart, compared to Cobactan 2.5%, which requires three daily injections. The recommended dose rate is 1 mL (3 mg cefquinome) per 25 kg bodyweight. The product isavailable in 50-ml, 100-ml and 250-ml glass vials.
Raul aded: "COBACTAN LA 7.5% also has a short withdrawal period of seven days. This makes the injectable product also safe to use throughout the finishing period for the treatment of SRD."
MSD adds that the use of COBACTAN LA 7.5% should be according to established responsible use guidelines and strictly according to the label instructions where specific restrictions apply to this class of antibiotics.
For more information, contact your local MSD Animal Health representative or go to www.msd-animal-health.com.
The announcement came hot on the heels of announcements from Ceva and Boehringer that they too had vaccines in the pipeline.
Syvazul BTV3 is licensed to reduce viraemia, prevent mortality and reduce clinical signs and lesions in sheep and for the active immunisation against bluetongue virus serotype 3 in cattle.
Like all vaccines currently available for this serotype, the vaccine will not prevent infection and vaccinated animals will still be subject to bluetongue movement controls and trade restrictions currently in place.
Administered as a single 2ml dose subcutaneously in sheep and as two 4ml intramuscular doses 3 weeks apart in cattle, Syvazul BTV3 contains inactivated Bluetongue virus, serotype 3 (BTV-3), strain BTV-3/NET2023.
The vaccine is licenced for use during pregnancy and lactation in both sheep and cattle.
The onset of immunity is 28 days after the primary vaccine in sheep. A single booster revaccination dose of 2ml for sheep and 4ml for cattle is recommended after 12 months.
Presented in two pack sizes, 80ml and 200ml, Syvazul BTV3 vaccine has a shelf life of 2 years from manufacture and a broach life of 10 hours.
Licensing for use will be geographic, based upon high risk counties or by specific licence from the APHA.
Liz Leece, an RCVS and EBVS specialist in veterinary anaesthesia and analgesia (pictured right) and Massimo Mariscoli, an EBVS and RCVS specialist in veterinary neurology joined Paragon at the start of this month.
Liz is a past president of the Association of Veterinary Anaesthetists, is on the British Small Animal Veterinary Association’s congress organising committee and lectures to vets, nurses and occasionally human anaesthetists, all over the world.
She said: "I’m a keen supporter of the anaesthetist’s role in the referral hospital setting, safeguarding welfare and optimising the hospital experience for all our patients.
"One of my first tasks will be to establish a chronic pain management clinic at Paragon to aid any patients in need of such support.
"I also love teaching both inside and outside clinics and I’m currently involved in clinical research into brachycephalics, neuroanaesthesia and chronic pain."
Massimo grew up in Italy and graduated from the University of Bologna in 1990. He worked as head of small animal surgery and neurology at the Veterinary Teaching Hospital of the University of Teramo, before spells as lecturer and associate professor at the same centre.
The past president of the Italian Society of Veterinary Neurology (SINVet) moved to the UK in May 2017 to work as a neurology specialist and then head of neurology at a small animal hospital.
His main clinical interests are epilepsy, inflammatory disorders of the central nervous system and neurosurgery.
He said: "I was looking for a new challenge and was very pleased when I learned there was the possibility of setting up the neurology service at Paragon. I first visited the site in February and got a very good impression.
"Neurology has been split between internal medicine and surgery to date, so I will be looking to establish the service in its own right.
"Setting up a new service and new systems can be complex, so I will be taking my time and letting the service take shape naturally."
Paragon managing director Ian Monteith said: "Both Liz and Massimo are tremendous additions to our team and we’re delighted to be adding yet more high-calibre specialists to our ranks."
For more information, visit www.paragonreferrals.co.uk.
Danilon is used to relieve the pain caused by musculoskeletal conditions, such as osteoarthritis (OA), bursitis, laminitis, and soft tissue inflammation.
Some oral NSAIDs have been shown to increase the risk of gastric irritation¹ - a particular concern when treating of chronic conditions.
However, Animalcare points to a study² in which horses given Danilon Gold showed a reduced number of ulcers and those that did appear were less severe.
The area of gastric mucosa affected was also five times less.
Animalcare says accurate administration is critical for clinical success.
To support this, Danilon Gold is presented in a coloured granule formulation and is now available in both 3g and 10g sachets.
ECM of France, a specialist in veterinary ultrasound solutions, has launched VIRTUAL SCAN - an ultrasound scanner for pig farmers and veterinarians. ECM says the scanner offers an alternative to screenless A-Mode Doppler devices, cheaper ultrasound devices, which are often poor quality.
VIRTUAL SCAN weighs 450 grams. It is equipped with an internal five-hour battery and a 5MHz sector probe. ECM says the instrument is extremely easy to handle - all the user needs to do is switch it on and the hand-held instrument is instantly ready to perform an ultrasound on sows.
VIRTUAL SCAN is a compact device (11cm x 18.5cm x 4.5cm) and does not require an external cable. According to the company, it can be used in any livestock facility, even inside narrow, hard-to-reach stalls. The screen is positioned in such a way that the image is always visible.
Using ECM's scanner, pregnancy tests can be performed as early as 21 days after insemination, so it is possible to re-inseminate any unfertilised sow without wasting a costly additional cycle. The image is easy to interpret. After use, the VIRTUAL SCAN ultrasound instrument is easy to clean with a damp cloth or water.
ECM, which is headquartered in Angoulême (in south-western France), develops and manufactures specialist veterinary-science devices. The company also provides training in ultrasound techniques, the correct way to move the probe and how to interpret the ultrasound image.
For more information, please contact:
Simon QuarmbyHOLMEFIELD Farm ServiceAgriculture HouseMurton LaneMurtonYorkT019 5UF
tel : (44) 1904 481.490fax : (44) 1904 481.211email : simon@hfsvets.com
Or visit: http://www.agroscan.com/ and http://www.ecmscan.com/
Invicta Animal Health has announced the launch of Ocuvance, a nutritional supplement to support ocular health in dogs and cats.
The company says Ocuvance is formulated to provide an antioxidant complex supporting and maintaining the health of eyes. The tablets contain lutein, a xanthophyll pigment found within the eye. They also contain anthocyanosides derived from bilberry extract to support rhodopsin production. The formulation also contains vitamins C and E, zinc and selenium.
Ocuvance is presented in packs of 30 scored tablets; sufficient for a one month supply for the average sized dog.
Rob Watkins, Managing Director of Invicta, said: "We are delighted to make Ocuvance available to veterinary surgeons in the UK. A recent veterinary study1 has shown there can be significant ophthalmic benefits of antioxidant supplementation.
We carefully formulated Ocuvance to provide a range of high quality ingredients to maintain normal visual function whilst still being affordable for owners”.
Ocuvance is now available from all veterinary wholesalers.
The new suite offers chemotherapy and radiotherapy treatment facilities under one roof, including a linear accelerator (LINAC) which enables treatment of tumours previously considered untreatable.
Southfields has two full-time client-facing specialists in radiation oncology and two on-site, full-time double-boarded medical and radiation oncologists, along with dedicated radiotherapy technicians and therapeutic radiographers.
RCVS and European Specialist Sarah Mason, Southfield's lead in general oncology, said: “Southfields is already renowned as being the leader in cancer treatment for small animals in the UK and the opening of our dedicated oncology and radiotherapy suite takes patient care to an even higher level.”
www.southfields.co.uk
Zoetis has launched Suvaxyn Parvo/E, a combined vaccine which it says provides the earliest protection of gilts against parvovirus and erysipelas.
Parvovirus and erysipelas infections occur primarily in gilts and sows, negatively impacting their reproductive success and the health of their litters - inevitably reducing profitability.
Nigel Lodge, National Veterinary Manager for Zoetis, said: "The combined vaccine will help ensure the health of gilts and sows is not affected by these two infections which are widespread in the pig herd.
"Suvaxyn® Parvo/E gives the earliest protection so that the ability to vaccinate gilts at five months of age will help ensure a good start to their reproductive life. Up to half of all pigs may be carriers of erysipelas and importantly the vaccine has licensed efficacy against both Erysipelothrix serotypes 1 and 2.
"This brings another vaccine to our portfolio, making it one of the largest in the pig sector and confirming the ongoing commitment of Zoetis to the health and welfare of pigs."
Suvaxyn® Parvo/E is an inactivated combination vaccine approved for immunising gilts and sows to prevent reproductive disorders caused by porcine parvovirus and reduce clinical signs caused by Erysipelothrix rhusiopathiae.
Primary vaccination is recommended from five months of age, with two injections given three to four weeks apart, ensuring the second dose occurs at least four weeks before mating. Revaccination should take place three to four weeks before each subsequent mating.
The vaccine comes in 10-dose and 2 X 25-dose packs. For more information, contact your Zoetis Pig Key Account Manager.
The course will be led by Dr Jon Hall, a European Specialist in Small Animal Surgery and Dr Danielle Gunn-Moore, an RCVS-recognised Specialist in Feline Medicine, supported by RVN Ms Claire Dorey-Phillips. It will take place at Improve’s new practical training facility in Sheffield in January 2019.
Improve says the programme will equip delegates with a full understanding of the causes of FLUTD and help them to advise owners with cats suffering from the condition in order to improve long-term outcomes. It will also provide a comprehensive overview of the nursing and medical options to treat feline idiopathic cystitis (FIC) and other causes of FLUTD including infection, calculi and neoplasia. The range of appropriate surgical methods to treat ureteral obstructions will also be covered, along with the post-operative nursing care, to ensure that delegates feel ready to perform a variety of bladder surgeries with confidence.
Juliet Pope MRCVS, Veterinary Operations Manager at Improve International (pictured right), said: "Treating patients with FLUTD is a team effort so we’re offering a special rate for a vet and nurse attending from the same practice though both vets and nurses can still, of course, book independently. The cutting-edge programme will be highly interactive and we aim to send delegates back to their practices with a revitalised approach to these tricky cat cases."
For further information visit www.improveinternational.com or email enquiries@improveinternational.com or call 01793 759159.
Following the outcry from the profession over the disciplinary hearing into Mr M Chikosi, the RCVS' new Operational Board has clarified the the College's position on the use of blankets to move animals.
The hearing found Munhuwepasi Chikosi guilty of unreasonably delaying attending a dog that had been run over at a farm, and of unnecessarily causing her to remain in pain and suffering for at least an hour.
As a result, the Disciplinary Committee directed that Mr Chikosi's name be removed from the Register for serious professional misconduct. The College says that since the appeal window has closed without an appeal being made, Mr Chikosi has now been struck off.
However, the Committee also said: "... his [Mr Chikosi's] advice that Mitzi should be moved on a blanket was wrong, as she may have had an injured back."
This was widely criticised as being out of touch with the practicalities of real life and unsupported by any evidence.
Speaking on behalf of the Board, President Neil Smith said: "We fully support the decision taken by the independent Disciplinary Committee with regard to the Chikosi hearing, with one comment requiring clarification: the issue of whether a blanket can be used to move an injured dog. We consider that it is acceptable, in most cases, to transport an injured dog with the aid of a blanket.
"The profession should be reassured that our Standards Committee [the new name for Advisory Committee] will consider the general issues raised by the Chikosi hearing at its next meeting. This will not be a review of the decision, but form part of the routine consideration of DC hearings made by the Committee to see if they raise issues that require additional guidance and advice."
The RCVS's new Royal Charter has come into effect today, meaning that the whole of the veterinary nursing profession in the UK is now regulated.
The new Charter received the Great Seal of the Realm and was collected from the House of Lords by RCVS Registrar Gordon Hockey and Policy Consultant Jeff Gill (pictured right). It had previously been approved at a meeting of the Privy Council on 5 November 2014.
Under the changes instituted in the new Charter, there are no longer listed veterinary nurses and all those formerly on the List have effectively been moved to the Register and become RVNs.
As a result they will now be expected to undertake the minimum requirement for continuing professional development (CPD) of 45 hours over a three-year period, will need to follow the RCVS Code of Professional Conduct for Veterinary Nurses,and will be subject to the College’s disciplinary system in cases of serious professional misconduct. Any veterinary nurse removed or suspended from the Register will not be entitled to give medical treatment or carry out minor surgery.
Gordon said: “This is a proud day for us and an important day for the profession as a whole. We worked very hard to get to this point and I would like to thank all those who helped us along the way including RCVS and VN Council members, College staff and the members of the profession and representative organisations, in particular the BVA and BVNA, that responded to our consultation on the proposed Charter last year.
“This Charter clarifies the role of the College and its aims and objectives while also modernising many of our regulatory functions. This represents another significant step towards the College becoming a first rate regulator.
“Critically, this Charter fulfils one of our long-term ambitions to create a coherent regulatory system for veterinary nurses and to recognise them as true professionals, dedicated to their vocation, their development and proper conduct.”
During this year’s renewal period for veterinary nurses (in the autumn), those formerly on the List will be expected to confirm that they are undertaking CPD and will also need to disclose any criminal convictions, cautions or adverse findings when they renew their registration. The annual renewal fee for veterinary nurses remains unchanged.
A detailed set of frequently asked questions for former listed veterinary nurses can be found at www.rcvs.org.uk/rvn.
The new facility will have 9 consultation rooms and 4 theatres, and is expected to open in early 2022.
It will be Animal Trust’s 10th veterinary hospital – with existing locations in Wrexham, Yorkshire and North England.
Animal Trust now employs more than 300 vets and veterinary care staff.
A further 15 jobs will be created in Rhyl when the new hospital opens.
Owen said: “Our ethos has always been that every animal deserves access to experienced and professional veterinary care as soon as they become ill.
"That’s why we offer free consultations for sick and injured animals brought to our surgeries.
"Our clients are from all walks of life and they come to us because of what we stand for and in some cases, for the prices we offer.
“As a CIC, we try and make sure that a comprehensive veterinary service is within reach of as many pet owners as possible.
"We build large veterinary hospitals that will serve the needs of the local pet-owning community and make a positive impact on their lives.
"Our new surgery will allow us to extend our services to the residents of the North Wales coastline, many of whom currently have to travel to one of our other existing surgeries.”
Funding for Animal Trust was provided by the £500 million Wales Flexible Investment Fund.
Vets Now launched the service at the start of the pandemic to provide remote veterinary advice, and it has now expanded from eight to nearly 30 emergency vets.
In 2022, Video Vets Now had over 13,000 consultations, with 80% of these occurring out-of-hours. Sundays are the busiest day, with almost a third of all consultations taking place.
Of these total consultations, 17% of pets were discharged normally, 7% were immediately referred in-clinic, and 48% were discharged as non-emergency cases, but with a recommendation to get a daytime vet appointment within 48 hours.
Dave Leicester, Vets Now’s head of telehealth says the fact that so few of Video Vets Now calls are referred on to a face-to-face consultation is a real benefit for pet owners and the veterinary profession: “Over two thirds of cases don’t need to be seen urgently by a vet.
"A lot of the cases are pet owners needing some clinical reassurance.
"As cases are triaged remotely, the service therefore frees up clinical staff for genuine emergencies.
“Additionally, without the service, many clients would have no other option than to attend for a full consultation at an out-of-hours clinic; so, clients save money too, allowing them to save their budget to spend at their daytime practices.
“Following the triage consultation, if the pet does need a non-urgent face-to-face consultation, we always direct clients to their registered vet. The £24 Video Vets Now consultation fee is then refunded.
"We call this our ‘Never Pay Twice’ promise, and it applies regardless of where that follow on consultation takes place.
"We see this as a win-win situation for clients and practices.”
Dave continued: “Over the past three years, Video Vets Now has seen unparalleled growth, providing essential care and reassurance for pet owners during a time of many challenges to traditional veterinary practice.
“As the pandemic has drawn to a close, we have consolidated our position as one of the UK's foremost providers of teletriage.
"Looking to the future, the changes in veterinary regulation will allow us to grow further and expand the range of services we can provide, bringing telehealth to an even greater number of pet owners.”
The Royal College of Veterinary Surgeons has launched its new website, which also marks the first public outing for its new livery.
The College highlights the following key changes:
The RCVS says the new corporate look is designed to be fresh, uncluttered and professional, and the new RCVS logo and strapline - "setting veterinary standards" - should leave visitors in no doubt as to the key purpose of the RCVS as a regulatory body. And whilst the new identity is modern in feel, the use of a shield device aims to maintain the link with the College's long history.
According to the College, the new brand was described by the veterinary surgeons and veterinary nurses who helped to develop it as "simple, clear and clean, with a strong message" and "modern and approachable".
President Peter Jinman said: "The College has been accused of being 'confused and confusing' in the past. With the new identity we have endeavoured to clarify that the College is a forward-thinking regulator - despite being established when Queen Victoria was only recently on the throne, and working to 45-year-old legislation.
"Changing the logo, font and colours we use is only a small part of the process though. Our branding review included several layers of research and we now have a better understanding of how we have been perceived, how we would like to be perceived, and what we need to do to get there. This includes changing how we behave and communicate as an organisation, as well as how we position ourselves to the outside world."
The new look, which includes new logos for RCVS Awards, the RCVS Charitable Trust and the Practice Standards Scheme, will be rolled out across other communications elements as the year unfolds, to avoid the unnecessary wastage of materials branded with the old identity.
Meanwhile, the website is a living medium, and the College says it is keen to hear feedback from users about what they like, and what could be improved, to help inform further developments.
The hour-long webinar will be held on Tuesday 18th May from 7.30pm.
Chris is a European and RCVS Recognised Specialist in Equine Dentistry and the founding Director of the Equine Dental Clinic Ltd. Nicole is a European, American and RCVS Recognised Specialist in Equine Dentistry and is a co-director of the Equine Dental Clinic.
Chris and Nicole (pictured right) will discuss key points for examination, diagnostics and treatment, including:
Zoetis Equine Product Manager, Penny McCann said: "Chris Pearce and Nicole du Toit are known worldwide for their consulting, training, educating and CPD, as well as for running the longest established and largest equine veterinary dental specialist practice in Europe.
"We are delighted that they have agreed to share their knowledge with our client practices on 18th May and look forward to welcoming you."
To book your place for the webinar, visit: https://register.gotowebinar.com/register/173596806534344203
For more information contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 8034.
The company's new van has a range of 146 miles before it needs recharging, and it can be recharged to 80% within 40 minutes.
That puts 60% of MWI's customers within range of its distribution centre in Stoke-on-Trent, including those in Manchester and Birmingham.
As part of its drive to establish more sustainable operations, MWI has also launched a pilot with one of its corporate customers in which they reduce the number of deliveries made per week – adopting a two or three-day a week delivery system.
The company says that since January, that has resulted in 700,000 fewer vehicle miles.